Moderna's messenger RNA vaccine for respiratory syncytial virus (RSV) has now been authorized by the FDA, a regulatory determination that comes almost a 12 months after GSK and Pfizer acquired regulatory approvals for his or her vaccines to forestall an infection by the seasonal respiratory virus . The FDA's determination introduced Friday impacts adults age 60 and older. Cambridge, Massachusetts-based […]